A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 07 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
- 12 Jul 2016 Planned primary completion date changed from 1 Dec 2015 to 1 May 2017.